| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Mignone Roberto serves as a Director at GH and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 2 buys and 6 sells.
Historically, Mignone Roberto's trades have earned a below-average insider score of 34/100 across 5 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -18.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | TEVA Teva Pharmaceutical Industries Limited | Director | Sell | 367,600 | $39.06 | $14,356,801.80 | -100% | - | - | |
| Dec 16, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Director | Sell | 77,400 | $30.24 | $2,340,645.66 | -17.4% | -2.1% | - | |
| Nov 26, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Director | Sell | 50,000 | $26.03 | $1,301,505.00 | -10.1% | +28.9% | - | |
| Nov 6, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Director | Sell | 200,000 | $24.11 | $4,821,880.00 | -28.8% | +42.9% | - | |
| Dec 20, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Director | Sell | 286,000 | $22.01 | $6,294,030.60 | -29.2% | -26.5% | +37.4% | |
| Jun 18, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Director | Sell | 519,000 | $17.03 | $8,838,570.00 | -34.6% | +6.2% | +0.3% | |
| May 10, 2018 | TEVA Teva Pharmaceutical Industries Ltd | Director | Buy | 750,000 | $19.24 | $14,432,850.00 | +100.0% | - | - |